- Home
- SPAI vs MBOT Comparison
SPAI vs MBOT Comparison
Compare SPAI & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPAI | MBOT |
|---|---|---|
| Founded | 2021 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.7M | 75.2M |
| IPO Year | 2024 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SPAI | MBOT |
|---|---|---|
| Price | $3.62 | $1.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $10.67 | $6.33 |
| AVG Volume (30 Days) | 175.1K | ★ 618.2K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,681.00 | $116,887.00 |
| Revenue This Year | $1,156.82 | N/A |
| Revenue Next Year | $143.48 | $475.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.23 | $1.01 |
| 52 Week High | $9.04 | $3.03 |
Technical Indicators
Market Signals| Indicator | SPAI | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 19.83 |
| Support Level | $3.64 | N/A |
| Resistance Level | $4.76 | $2.21 |
| Average True Range (ATR) | 0.40 | 0.06 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 9.02 | 1.52 |
Price Performance
Historical ComparisonAbout SPAI Safe Pro Group Inc.
Safe Pro Group Inc operates to acquire security and protection products. The company operated in three reportable business segments, which consisted of the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. The majority of revenue is from Safe-Pro USA.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.